vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and Arteris, Inc. (AIP). Click either name above to swap in a different company.
Arteris, Inc. is the larger business by last-quarter revenue ($20.1M vs $20.0M, roughly 1.0× AGIOS PHARMACEUTICALS, INC.). Arteris, Inc. runs the higher net margin — -42.2% vs -541.1%, a 498.9% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 30.0%). Arteris, Inc. produced more free cash flow last quarter ($3.0M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 24.7%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...
AGIO vs AIP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $20.1M |
| Net Profit | $-108.0M | $-8.5M |
| Gross Margin | 90.6% | 90.8% |
| Operating Margin | -608.9% | -42.0% |
| Net Margin | -541.1% | -42.2% |
| Revenue YoY | 86.1% | 30.0% |
| Net Profit YoY | -11.9% | -3.7% |
| EPS (diluted) | $-1.86 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $20.1M | ||
| Q3 25 | $12.9M | $17.4M | ||
| Q2 25 | $12.5M | $16.5M | ||
| Q1 25 | $8.7M | $16.5M | ||
| Q4 24 | $10.7M | $15.5M | ||
| Q3 24 | $9.0M | $14.7M | ||
| Q2 24 | $8.6M | $14.6M | ||
| Q1 24 | $8.2M | $12.9M |
| Q4 25 | $-108.0M | $-8.5M | ||
| Q3 25 | $-103.4M | $-9.0M | ||
| Q2 25 | $-112.0M | $-9.1M | ||
| Q1 25 | $-89.3M | $-8.1M | ||
| Q4 24 | $-96.5M | $-8.2M | ||
| Q3 24 | $947.9M | $-7.7M | ||
| Q2 24 | $-96.1M | $-8.3M | ||
| Q1 24 | $-81.5M | $-9.4M |
| Q4 25 | 90.6% | 90.8% | ||
| Q3 25 | 87.0% | 89.9% | ||
| Q2 25 | 86.3% | 89.4% | ||
| Q1 25 | 87.6% | 90.8% | ||
| Q4 24 | 88.3% | 89.8% | ||
| Q3 24 | 91.3% | 90.1% | ||
| Q2 24 | 82.6% | 90.0% | ||
| Q1 24 | 92.3% | 88.7% |
| Q4 25 | -608.9% | -42.0% | ||
| Q3 25 | -907.4% | -50.1% | ||
| Q2 25 | -1020.1% | -50.0% | ||
| Q1 25 | -1222.0% | -46.6% | ||
| Q4 24 | -1165.3% | -45.9% | ||
| Q3 24 | -1146.9% | -53.8% | ||
| Q2 24 | -1228.3% | -51.1% | ||
| Q1 24 | -1124.3% | -70.5% |
| Q4 25 | -541.1% | -42.2% | ||
| Q3 25 | -803.1% | -51.6% | ||
| Q2 25 | -899.4% | -55.3% | ||
| Q1 25 | -1023.3% | -49.1% | ||
| Q4 24 | -899.6% | -53.0% | ||
| Q3 24 | 10574.7% | -52.2% | ||
| Q2 24 | -1115.7% | -57.2% | ||
| Q1 24 | -995.8% | -72.6% |
| Q4 25 | $-1.86 | $-0.19 | ||
| Q3 25 | $-1.78 | $-0.21 | ||
| Q2 25 | $-1.93 | $-0.22 | ||
| Q1 25 | $-1.55 | $-0.20 | ||
| Q4 24 | $-1.44 | $-0.19 | ||
| Q3 24 | $16.22 | $-0.20 | ||
| Q2 24 | $-1.69 | $-0.22 | ||
| Q1 24 | $-1.45 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $33.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $-14.6M |
| Total Assets | $1.3B | $115.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $33.9M | ||
| Q3 25 | $92.7M | $39.0M | ||
| Q2 25 | $80.9M | $38.0M | ||
| Q1 25 | $79.0M | $42.3M | ||
| Q4 24 | $76.2M | $43.8M | ||
| Q3 24 | $253.7M | $48.7M | ||
| Q2 24 | $84.5M | $45.8M | ||
| Q1 24 | $118.8M | $44.8M |
| Q4 25 | $1.2B | $-14.6M | ||
| Q3 25 | $1.3B | $-11.4M | ||
| Q2 25 | $1.4B | $-7.5M | ||
| Q1 25 | $1.5B | $-4.8M | ||
| Q4 24 | $1.5B | $-1.2M | ||
| Q3 24 | $1.6B | $2.2M | ||
| Q2 24 | $660.5M | $5.3M | ||
| Q1 24 | $743.9M | $9.5M |
| Q4 25 | $1.3B | $115.0M | ||
| Q3 25 | $1.4B | $107.7M | ||
| Q2 25 | $1.5B | $106.9M | ||
| Q1 25 | $1.6B | $98.3M | ||
| Q4 24 | $1.7B | $106.1M | ||
| Q3 24 | $1.8B | $97.7M | ||
| Q2 24 | $773.1M | $96.4M | ||
| Q1 24 | $849.7M | $101.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $3.2M |
| Free Cash FlowOCF − Capex | $-97.3M | $3.0M |
| FCF MarginFCF / Revenue | -487.5% | 15.1% |
| Capex IntensityCapex / Revenue | 5.6% | 0.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $5.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $3.2M | ||
| Q3 25 | $-88.2M | $3.2M | ||
| Q2 25 | $-77.1M | $-2.5M | ||
| Q1 25 | $-111.5M | $2.9M | ||
| Q4 24 | $-133.2M | $-2.6M | ||
| Q3 24 | $-84.2M | $1.1M | ||
| Q2 24 | $-72.6M | $311.0K | ||
| Q1 24 | $-99.9M | $477.0K |
| Q4 25 | $-97.3M | $3.0M | ||
| Q3 25 | $-89.7M | $2.5M | ||
| Q2 25 | $-78.0M | $-2.8M | ||
| Q1 25 | $-112.3M | $2.7M | ||
| Q4 24 | $-134.1M | $-2.7M | ||
| Q3 24 | $-84.6M | $1.1M | ||
| Q2 24 | $-72.7M | $264.0K | ||
| Q1 24 | $-100.0M | $281.0K |
| Q4 25 | -487.5% | 15.1% | ||
| Q3 25 | -696.5% | 14.2% | ||
| Q2 25 | -626.2% | -17.2% | ||
| Q1 25 | -1286.4% | 16.2% | ||
| Q4 24 | -1250.1% | -17.3% | ||
| Q3 24 | -944.2% | 7.4% | ||
| Q2 24 | -844.4% | 1.8% | ||
| Q1 24 | -1221.2% | 2.2% |
| Q4 25 | 5.6% | 0.7% | ||
| Q3 25 | 12.1% | 4.1% | ||
| Q2 25 | 7.0% | 2.2% | ||
| Q1 25 | 8.8% | 1.1% | ||
| Q4 24 | 9.0% | 0.3% | ||
| Q3 24 | 4.7% | 0.2% | ||
| Q2 24 | 1.8% | 0.3% | ||
| Q1 24 | 1.7% | 1.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
AIP
| License And Maintenance | $17.5M | 87% |
| Variable Royalties And Other | $2.6M | 13% |
